Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.

Wilstermann AM, Osheroff N.

Curr Top Med Chem. 2003;3(3):321-38. Review.

PMID:
12570766
2.

DNA topoisomerase II as a target for cancer chemotherapy.

Walker JV, Nitiss JL.

Cancer Invest. 2002;20(4):570-89. Review. No abstract available.

PMID:
12094551
3.

Sensing and repairing DNA double-strand breaks.

Jackson SP.

Carcinogenesis. 2002 May;23(5):687-96. Review.

PMID:
12016139
4.

DNA double-strand break repair from head to tail.

Hopfner KP, Putnam CD, Tainer JA.

Curr Opin Struct Biol. 2002 Feb;12(1):115-22. Review.

PMID:
11839498
5.

Removal of a single alpha-tubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in Saccharomyces cerevisiae.

Burns CG, Ohi R, Mehta S, O'Toole ET, Winey M, Clark TA, Sugnet CW, Ares M Jr, Gould KL.

Mol Cell Biol. 2002 Feb;22(3):801-15.

6.

Double-strand breaks and tumorigenesis.

Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M.

Trends Cell Biol. 2001 Nov;11(11):S52-9. Review.

PMID:
11684443
7.

Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

Lovett BD, Lo Nigro L, Rappaport EF, Blair IA, Osheroff N, Zheng N, Megonigal MD, Williams WR, Nowell PC, Felix CA.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9802-7. Epub 2001 Aug 7.

8.

DNA topoisomerases: structure, function, and mechanism.

Champoux JJ.

Annu Rev Biochem. 2001;70:369-413. Review.

PMID:
11395412
9.

Double-strand-break-induced homologous recombination in mammalian cells.

Johnson RD, Jasin M.

Biochem Soc Trans. 2001 May;29(Pt 2):196-201. Review.

PMID:
11356153
10.

Leukemias related to treatment with DNA topoisomerase II inhibitors.

Felix CA.

Med Pediatr Oncol. 2001 May;36(5):525-35. Review.

PMID:
11340607
11.

Tumor cell death induced by topoisomerase-targeting drugs.

Li TK, Liu LF.

Annu Rev Pharmacol Toxicol. 2001;41:53-77. Review.

PMID:
11264450
12.

DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.

Byl JA, Cline SD, Utsugi T, Kobunai T, Yamada Y, Osheroff N.

Biochemistry. 2001 Jan 23;40(3):712-8.

PMID:
11170388
13.

Genetic analysis of homologous DNA recombination in vertebrate somatic cells.

Morrison C, Takeda S.

Int J Biochem Cell Biol. 2000 Aug;32(8):817-31. Review.

PMID:
10940640
14.

Tying up loose ends: nonhomologous end-joining in Saccharomyces cerevisiae.

Lewis LK, Resnick MA.

Mutat Res. 2000 Jun 30;451(1-2):71-89. Review.

PMID:
10915866
15.

Frequent chromosomal translocations induced by DNA double-strand breaks.

Richardson C, Jasin M.

Nature. 2000 Jun 8;405(6787):697-700.

PMID:
10864328
16.

Mitotic recombination in yeast: elements controlling its incidence.

Aguilera A, Chávez S, Malagón F.

Yeast. 2000 Jun 15;16(8):731-54. Review.

17.

Partners and pathwaysrepairing a double-strand break.

Haber JE.

Trends Genet. 2000 Jun;16(6):259-64. Review.

PMID:
10827453
18.

Recombination: a frank view of exchanges and vice versa.

Haber JE.

Curr Opin Cell Biol. 2000 Jun;12(3):286-92. Review.

PMID:
10801454
19.
20.

Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.

Pichierri P, Franchitto A, Mosesso P, Proietti de Santis L, Balajee AS, Palitti F.

Mutat Res. 2000 Mar 20;459(2):123-33.

PMID:
10725663

Supplemental Content

Support Center